Novel dihydropyridines as potential calcium-channel and P-glycoprotein blockers applicable for chemotherapy sensitization
Bioorganic Chemistry · 2025
DOI: 10.1016/j.bioorg.2025.109072 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2025. Verfasst von Gang Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Province Key Laboratory of Biotechnology of Chinese Traditional Medicine, College of Health Science and Engineering, Hubei University, Wuhan 43…. Hauptthemen laut MEDLINE: Dihydropyridines, Calcium Channel Blockers, Antineoplastic Agents, ATP Binding Cassette Transporter, Subfamily B, Member 1. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Chongqing Municipal Education Commission, Hubei Province Natural Science Foundation, National Natural Science Foundation of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
P-glycoprotein (P-gp)-mediated multidrug resistance in tumors is one of the main reasons for chemotherapy failure. For hypertensive patients undergoing long-term chemotherapy, antihypertensive drugs with P-gp inhibitory effects are expected to substantially reduce the dosage of chemotherapeutic agents. 1,4-Dihydropyridines (DHPs), as classical calcium channel blockers, have been widely used in clinical hypertension treatment. In this study, novel dihydropyridines, namely HCAs, were designed and evaluated for their ability to reverse multidrug resistance. HCAs exerted synergistic effects on calcium channels and P-gp, potentially alleviating hypertension while sensitizing tumors to chemotherapy. Low concentrations of HCAs significantly enhanced the sensitivity of tumor cells to cisplatin; notably, 2 μM HCA-6 increased the inhibitory effect of cisplatin on HeLa cells by 61.21 %. Overall, HCAs hold promises for benefiting hypertensive patients with long-term cancer conditions and reducing reliance on high-dose chemotherapeutic agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hubei Province Key Laboratory of Biotechnology of Chinese Traditional Medicine, College of Health Science and Engineering, Hubei University, Wuhan 430062, China.
- Hubei Province Key Laboratory of Biotechnology of Chinese Traditional Medicine, College of Health Science and Engineering, Hubei University, Wuhan 430062, China; Department of Endocrinology, Liangjiang Hospital of Chong…
- Department of Endocrinology, Liangjiang Hospital of Chongqing Medical University, People's Hospital of Chongqing Liangjiang New Area, Chongqing 400000, China. Electronic address: zhanghongmin0501@163.com.
- School of Life Science, Hubei University, Wuhan 430062, China.
- Hubei Province Key Laboratory of Biotechnology of Chinese Traditional Medicine, College of Health Science and Engineering, Hubei University, Wuhan 430062, China; Hubei Jiangxia Laboratory, Wuhan 430200, Hubei, PR China.…
- Hubei Province Key Laboratory of Biotechnology of Chinese Traditional Medicine, College of Health Science and Engineering, Hubei University, Wuhan 430062, China. Electronic address: j.pan@hubu.edu.cn.
Förderung
- Chongqing Municipal Education Commission
- Hubei Province Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Chen, G., Zhong, S., Zhong, C., Zhang, H., Ishaq, A. R., Li, Y., Yang, L., Wang, K., Pan, J., & Li, X. (2025). Novel dihydropyridines as potential calcium-channel and P-glycoprotein blockers applicable for chemotherapy sensitization. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2025.109072
Vancouver
Chen G, Zhong S, Zhong C, Zhang H, Ishaq AR, Li Y, et al. Novel dihydropyridines as potential calcium-channel and P-glycoprotein blockers applicable for chemotherapy sensitization. Bioorganic Chemistry. 2025. doi:10.1016/j.bioorg.2025.109072
BibTeX
@article{Chen2025,
author = {Chen, Gang and Zhong, Shiyi and Zhong, Chunxu and Zhang, Hongmin and Ishaq, Ali Raza and Li, Yanrong and Yang, Liuxin and Wang, Kai and Pan, Jie and Li, Xiang},
title = {Novel dihydropyridines as potential calcium-channel and P-glycoprotein blockers applicable for chemotherapy sensitization},
journal = {Bioorganic Chemistry},
year = {2025},
doi = {10.1016/j.bioorg.2025.109072}
}
EUVIMED